Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2022 Filed Mar 2, 2022 00:00 UTC |
Harrod Laurence L.EVP of Finance
|
GrantCommon Stock | 55,761 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-008404 · doc4.xml · nonDerivative · entry 1 Harrod Laurence L. · CIK 0001785450 · EVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,324 F1 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on August 14, 2019. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 18:50 UTC |
OSTEEN DEBRA KDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 27,403 | $52.31 | $1,433,450.93 |
DisclosureSEC source: 0000899243-22-004208 · doc4.xml · nonDerivative · entry 1 OSTEEN DEBRA K · CIK 0001181035 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,665 Read SEC document |
| August 14, 2021 Filed Aug 16, 2021 17:01 UTC |
Hollinsworth John S.EVP of Operations
|
Tax withholdingCommon Stock | 1,115 | $61.90 | $69,018.50 |
DisclosureSEC source: 0000899243-21-033124 · doc4.xml · nonDerivative · entry 1 Hollinsworth John S. · CIK 0001782021 · EVP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,160 Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 17:05 UTC |
Hollinsworth John S.EVP of Operations
|
SaleCommon Stock | 5,000 | $66.31 | $331,550.00 |
DisclosureSEC source: 0000899243-21-024163 · doc4.xml · nonDerivative · entry 1 Hollinsworth John S. · CIK 0001782021 · EVP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,275 Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 21:05 UTC |
WAUD REEVE BDirector
|
SaleCommon Stock, par value $0.01 per share | 27,515 | $66.47 | $1,828,922.05 |
DisclosureSEC source: 0000899243-21-024164 · doc4.xml · nonDerivative · entry 3 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 506,844 F6 · shares: Represents shares sold by the 2012 CRMW Family Trust. F7 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $66.27 to $66.97, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are owned of record as follows: (i) 157,491 shares by the Halcyon Exempt Family Trust (the "Halcyon Trust"), (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 155,930 shares by the 2012 RBW Jr Family Trust, and (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust"). F4 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (2) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, and (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries. F5 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 21:05 UTC |
WAUD REEVE BDirector
|
SaleCommon Stock, par value $0.01 per share | 27,515 | $66.47 | $1,828,922.05 |
DisclosureSEC source: 0000899243-21-024164 · doc4.xml · nonDerivative · entry 2 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 534,359 F1 · shares: Represents shares sold by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"). F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $66.27 to $66.89, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The shares are owned of record as follows: (i) 157,491 shares by the Halcyon Exempt Family Trust (the "Halcyon Trust"), (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 155,930 shares by the 2012 RBW Jr Family Trust, and (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust"). F4 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (2) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, and (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries. F5 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 06, 2021 Filed May 7, 2021 21:05 UTC |
Fucci MichaelDirector
|
GrantCommon Stock | 2,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018709 · doc4.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,843 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 6, 2022. Read SEC document |
| May 06, 2021 Filed May 7, 2021 21:05 UTC |
WAUD REEVE BDirector
|
GrantCommon Stock, par value $0.01 per share | 2,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018708 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,315 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 6, 2022. Read SEC document |
| May 06, 2021 Filed May 7, 2021 21:05 UTC |
Bissell E. PerotDirector
|
GrantCommon Stock | 2,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018712 · doc4.xml · nonDerivative · entry 1 Bissell E. Perot · CIK 0001420194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,677 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 6, 2022. Read SEC document |
| May 06, 2021 Filed May 7, 2021 17:05 UTC |
Petrie William MDirector
|
GrantCommon Stock | 2,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018715 · doc4.xml · nonDerivative · entry 1 Petrie William M · CIK 0001302671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,466 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 6, 2022. Read SEC document |
| May 06, 2021 Filed May 7, 2021 21:05 UTC |
GRIECO WILLIAMDirector
|
GrantCommon Stock | 2,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018714 · doc4.xml · nonDerivative · entry 1 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,508 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 6, 2022. Read SEC document |
| May 06, 2021 Filed May 7, 2021 17:05 UTC |
Miquelon Wade DDirector
|
GrantCommon Stock | 2,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018710 · doc4.xml · nonDerivative · entry 1 Miquelon Wade D · CIK 0001365176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,745 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 6, 2022. Read SEC document |
| May 06, 2021 Filed May 7, 2021 21:05 UTC |
Gregg Vicky BDirector
|
GrantCommon Stock | 2,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018711 · doc4.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,819 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 6, 2022. Read SEC document |
| May 06, 2021 Filed May 7, 2021 21:05 UTC |
Bernhard JasonDirector
|
GrantCommon Stock | 2,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018713 · doc4.xml · nonDerivative · entry 1 Bernhard Jason · CIK 0001798185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,904 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 6, 2022. Read SEC document |
| May 02, 2021 Filed May 4, 2021 17:05 UTC |
Howard Christopher LEVP, GC and Secretary
|
Tax withholdingCommon Stock | 956 | $60.92 | $58,239.52 |
DisclosureSEC source: 0000899243-21-018152 · doc4.xml · nonDerivative · entry 1 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,495 Read SEC document |
| May 02, 2021 Filed May 4, 2021 21:05 UTC |
Duckworth David M.Chief Financial Officer
|
Tax withholdingCommon Stock | 946 | $60.92 | $57,630.32 |
DisclosureSEC source: 0000899243-21-018153 · doc4.xml · nonDerivative · entry 1 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,927 Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 17:10 UTC |
Hollinsworth John S.EVP of Operations
|
GrantCommon Stock | 5,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-017117 · doc4.xml · nonDerivative · entry 1 Hollinsworth John S. · CIK 0001782021 · EVP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,275 F1 · shares: Shares will vest over a 4-year period in equal yearly installments beginning April 23, 2022. Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 17:10 UTC |
Howard Christopher LEVP, GC and Secretary
|
GrantCommon Stock | 5,477 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-017116 · doc4.xml · nonDerivative · entry 1 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,451 F1 · shares: Shares will vest over a 4-year period in equal yearly installments beginning April 23, 2022. Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 21:10 UTC |
Harrod Laurence L.EVP of Finance
|
GrantCommon Stock | 5,213 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-017119 · doc4.xml · nonDerivative · entry 1 Harrod Laurence L. · CIK 0001785450 · EVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,563 F1 · shares: Shares will vest over a 4-year period in equal yearly installments beginning April 23, 2022. Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 21:10 UTC |
Duckworth David M.Chief Financial Officer
|
GrantCommon Stock | 5,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-017118 · doc4.xml · nonDerivative · entry 1 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,873 F1 · shares: Shares will vest over a 4-year period in equal yearly installments beginning April 23, 2022. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 17:05 UTC |
Hollinsworth John S.EVP of Operations
|
Tax withholdingCommon Stock | 2,802 | $55.02 | $154,166.04 |
DisclosureSEC source: 0000899243-21-013702 · doc4.xml · nonDerivative · entry 1 Hollinsworth John S. · CIK 0001782021 · EVP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,655 Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 21:10 UTC |
GRIECO WILLIAMDirector
|
SaleCommon Stock | 2,000 | $60.65 | $121,300.00 |
DisclosureSEC source: 0000899243-21-011976 · doc4.xml · nonDerivative · entry 2 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,958 Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 22:27 UTC |
WAUD REEVE BDirector
|
SaleCommon Stock, par value $0.01 per share | 109,443 | $59.12 | $6,470,357.71 |
DisclosureSEC source: 0000899243-21-011682 · doc4.xml · nonDerivative · entry 2 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 561,874 F1 · shares: Represents shares sold by the Halcyon Exempt Family Trust (the "Halcyon Trust"). F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $58.82 to $59.50, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Following both of the transactions reported in this Form 4, the shares are owned of record as follows: (i) 157,491 shares by the Halcyon Trust, (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), and (iv) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust"). F4 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (3) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, and (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries. F5 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 21:10 UTC |
GRIECO WILLIAMDirector
|
SaleCommon Stock | 2,000 | $59.02 | $118,040.00 |
DisclosureSEC source: 0000899243-21-011976 · doc4.xml · nonDerivative · entry 1 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,958 Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 17:01 UTC |
Howard Christopher LEVP, GC and Secretary
|
Exercise / conversionStock Option · Derivative | 9,500 | $0.00 Strike: $29.39 | $0.00 |
DisclosureSEC source: 0000899243-21-011600 · doc4.xml · derivative · entry 7 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,500 shares Expires 2023-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 17:01 UTC |
Howard Christopher LEVP, GC and Secretary
|
Exercise / conversionStock Option · Derivative | 6,466 | $0.00 Strike: $15.96 | $0.00 |
DisclosureSEC source: 0000899243-21-011600 · doc4.xml · derivative · entry 6 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,466 shares Expires 2022-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 17:01 UTC |
Howard Christopher LEVP, GC and Secretary
|
Exercise / conversionCommon Stock | 9,500 | $29.39 | $279,205.00 |
DisclosureSEC source: 0000899243-21-011600 · doc4.xml · nonDerivative · entry 4 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 17:01 UTC |
Howard Christopher LEVP, GC and Secretary
|
Exercise / conversionCommon Stock | 6,466 | $15.96 | $103,197.36 |
DisclosureSEC source: 0000899243-21-011600 · doc4.xml · nonDerivative · entry 3 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 17:01 UTC |
Howard Christopher LEVP, GC and Secretary
|
SaleCommon Stock | 33,228 | $58.09 | $1,930,214.52 |
DisclosureSEC source: 0000899243-21-011600 · doc4.xml · nonDerivative · entry 2 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,008 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.18, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 21:06 UTC |
Duckworth David M.Chief Financial Officer
|
Exercise / conversionStock Option · Derivative | 9,500 | $0.00 Strike: $29.39 | $0.00 |
DisclosureSEC source: 0000899243-21-011603 · doc4.xml · derivative · entry 9 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,500 shares Expires 2023-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 21:06 UTC |
Duckworth David M.Chief Financial Officer
|
Exercise / conversionStock Option · Derivative | 7,591 | $0.00 Strike: $16.60 | $0.00 |
DisclosureSEC source: 0000899243-21-011603 · doc4.xml · derivative · entry 8 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,591 shares Expires 2022-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 21:06 UTC |
Duckworth David M.Chief Financial Officer
|
Exercise / conversionStock Option · Derivative | 814 | $0.00 Strike: $15.96 | $0.00 |
DisclosureSEC source: 0000899243-21-011603 · doc4.xml · derivative · entry 7 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 814 shares Expires 2022-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 21:06 UTC |
Duckworth David M.Chief Financial Officer
|
Exercise / conversionStock Option · Derivative | 875 | $0.00 Strike: $9.40 | $0.00 |
DisclosureSEC source: 0000899243-21-011603 · doc4.xml · derivative · entry 6 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 875 shares Expires 2021-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 21:06 UTC |
Duckworth David M.Chief Financial Officer
|
Exercise / conversionCommon Stock | 9,500 | $29.39 | $279,205.00 |
DisclosureSEC source: 0000899243-21-011603 · doc4.xml · nonDerivative · entry 5 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 21:06 UTC |
Duckworth David M.Chief Financial Officer
|
Exercise / conversionCommon Stock | 7,591 | $16.60 | $126,010.60 |
DisclosureSEC source: 0000899243-21-011603 · doc4.xml · nonDerivative · entry 4 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 21:06 UTC |
Duckworth David M.Chief Financial Officer
|
Exercise / conversionCommon Stock | 814 | $15.96 | $12,991.44 |
DisclosureSEC source: 0000899243-21-011603 · doc4.xml · nonDerivative · entry 3 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 21:06 UTC |
Duckworth David M.Chief Financial Officer
|
Exercise / conversionCommon Stock | 875 | $9.40 | $8,225.00 |
DisclosureSEC source: 0000899243-21-011603 · doc4.xml · nonDerivative · entry 2 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 21:06 UTC |
Duckworth David M.Chief Financial Officer
|
SaleCommon Stock | 18,780 | $58.04 | $1,089,991.20 |
DisclosureSEC source: 0000899243-21-011603 · doc4.xml · nonDerivative · entry 1 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,773 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.10, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 07, 2021 Filed Mar 9, 2021 17:01 UTC |
Hollinsworth John S.EVP of Operations
|
Tax withholdingCommon Stock | 1,375 | $54.98 | $75,597.50 |
DisclosureSEC source: 0000899243-21-010695 · doc4.xml · nonDerivative · entry 1 Hollinsworth John S. · CIK 0001782021 · EVP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,457 Read SEC document |
| March 05, 2021 Filed Mar 15, 2021 17:01 UTC |
Howard Christopher LEVP, GC and Secretary
|
GiftCommon Stock | 7,359 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-011600 · doc4.xml · nonDerivative · entry 5 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 93,616 F1 · kind: This transaction involved a gift of 7,359 shares by the Christopher L. Howard Family 2017 Grantor Retained Annuity Trust to the reporting person. F3 · balance_after: Mr. Howard expressly disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. F4 · ownership.nature: Includes 33,616 shares held by the Christopher L. Howard Family 2017 Grantor Retained Annuity Trust, 33,616 shares held by the Angie Parrott Howard Family 2017 Grantor Retained Annuity Trust and 26,384 shares held by the reporting person's spouse. Read SEC document |
| March 05, 2021 Filed Mar 15, 2021 17:01 UTC |
Howard Christopher LEVP, GC and Secretary
|
GiftCommon Stock | 7,359 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-011600 · doc4.xml · nonDerivative · entry 1 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,236 F1 · kind: This transaction involved a gift of 7,359 shares by the Christopher L. Howard Family 2017 Grantor Retained Annuity Trust to the reporting person. Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 17:20 UTC |
Howard Christopher LEVP, GC and Secretary
|
Tax withholdingCommon Stock | 801 | $56.04 | $44,888.04 |
DisclosureSEC source: 0000899243-21-009020 · doc4.xml · nonDerivative · entry 3 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,877 Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 22:02 UTC |
Duckworth David M.Chief Financial Officer
|
Tax withholdingCommon Stock | 694 | $56.04 | $38,891.76 |
DisclosureSEC source: 0000899243-21-009010 · doc4.xml · nonDerivative · entry 3 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,553 Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 17:20 UTC |
Howard Christopher LEVP, GC and Secretary
|
Tax withholdingCommon Stock | 9,849 | $55.24 | $544,058.76 |
DisclosureSEC source: 0000899243-21-009020 · doc4.xml · nonDerivative · entry 2 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,678 Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 17:20 UTC |
Howard Christopher LEVP, GC and Secretary
|
GrantCommon Stock | 25,875 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009020 · doc4.xml · nonDerivative · entry 1 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,527 F1 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on March 2, 2018. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 22:02 UTC |
Duckworth David M.Chief Financial Officer
|
Tax withholdingCommon Stock | 8,440 | $55.24 | $466,225.60 |
DisclosureSEC source: 0000899243-21-009010 · doc4.xml · nonDerivative · entry 2 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,247 Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 22:02 UTC |
Duckworth David M.Chief Financial Officer
|
GrantCommon Stock | 22,424 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009010 · doc4.xml · nonDerivative · entry 1 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,687 F1 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on March 2, 2018. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:02 UTC |
GRIECO WILLIAMDirector
|
Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.60 | $0.00 |
DisclosureSEC source: 0000899243-20-034127 · doc4.xml · derivative · entry 2 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2020-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:02 UTC |
GRIECO WILLIAMDirector
|
Exercise / conversionCommon Stock | 5,000 | $6.60 | $33,000.00 |
DisclosureSEC source: 0000899243-20-034127 · doc4.xml · nonDerivative · entry 1 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2020 Filed Oct 30, 2020 21:05 UTC |
Fucci MichaelDirector
|
GrantCommon Stock | 5,293 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-029941 · doc4.xml · nonDerivative · entry 1 Fucci Michael · CIK 0001830184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,293 F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning October 28, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.